Letter to the Editor
Split Viewer
Blood Res 2014; 49(4):
Published online December 31, 2014
https://doi.org/10.5045/br.2014.49.4.279
© The Korean Society of Hematology
Tumor flare reaction in a patient with mantle cell lymphoma
1Bezmialem Vakif University, Department of Internal Medicine, Istanbul, Turkey.
2Bagcilar Education & Research Hospital, Department of Family Medicine, Istanbul, Turkey.
Correspondence to : Yusuf Kayar. BezmialemVakif University, Department of Internal Medicine, Vatan Street, Fatih, Istanbul 34093, Turkey. ykayar@yahoo.com
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
FIGURES
Fig. 1. The patient's throat magnetic resonance imaging scan showing a heterogeneously dense mass, sized approximately 65×29 mm at its broadest point, with its borders not clearly identified; therefore, the mass caused distinct asymmetry in the hypopharynx and oropharynx, displaced the uvula to the right side, and continued to the epiglottis level.
REFERENCES
- Andritsos, LA, Johnson, AJ, Lozanski, G, et al. Higher doses of lenalidomide are associated with unacceptable toxicity including life-threatening tumor flare in patients with chronic lymphocytic leukemia. J Clin Oncol, 2008;26;2519-2525.
- Chanan-Khan, A, Miller, KC, Musial, L, et al. Clinical efficacy of lenalidomide in patients with relapsed or refractory chronic lymphocytic leukemia: results of a phase II study. J Clin Oncol, 2006;24;5343-5349.
- Ferrajoli, A, Lee, BN, Schlette, EJ, et al. Lenalidomide induces complete and partial remissions in patients with relapsed and refractory chronic lymphocytic leukemia. Blood, 2008;111;5291-5297.
- Corazzelli, G, De Filippi, R, Capobianco, G, et al. Tumor flare reactions and response to lenalidomide in patients with refractory classic Hodgkin lymphoma. Am J Hematol, 2010;85;87-90.
- Eve, HE, Rule, SA. Lenalidomide-induced tumour flare reaction in mantle cell lymphoma. Br J Haematol, 2010;151;410-412.
PDF
Standard view
Export citation
Share Article
Letter to the Editor
Blood Res 2014; 49(4): 279-280
Published online December 31, 2014 https://doi.org/10.5045/br.2014.49.4.279
Copyright © The Korean Society of Hematology.
Tumor flare reaction in a patient with mantle cell lymphoma
Yusuf Kayar1*, and Nuket Bayram Kayar2
1Bezmialem Vakif University, Department of Internal Medicine, Istanbul, Turkey.
2Bagcilar Education & Research Hospital, Department of Family Medicine, Istanbul, Turkey.
Correspondence to: Yusuf Kayar. BezmialemVakif University, Department of Internal Medicine, Vatan Street, Fatih, Istanbul 34093, Turkey. ykayar@yahoo.com
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Fig 1.
Download
The patient's throat magnetic resonance imaging scan showing a heterogeneously dense mass, sized approximately 65×29 mm at its broadest point, with its borders not clearly identified; therefore, the mass caused distinct asymmetry in the hypopharynx and oropharynx, displaced the uvula to the right side, and continued to the epiglottis level.
References
- Andritsos, LA, Johnson, AJ, Lozanski, G, et al. Higher doses of lenalidomide are associated with unacceptable toxicity including life-threatening tumor flare in patients with chronic lymphocytic leukemia. J Clin Oncol, 2008;26;2519-2525.
- Chanan-Khan, A, Miller, KC, Musial, L, et al. Clinical efficacy of lenalidomide in patients with relapsed or refractory chronic lymphocytic leukemia: results of a phase II study. J Clin Oncol, 2006;24;5343-5349.
- Ferrajoli, A, Lee, BN, Schlette, EJ, et al. Lenalidomide induces complete and partial remissions in patients with relapsed and refractory chronic lymphocytic leukemia. Blood, 2008;111;5291-5297.
- Corazzelli, G, De Filippi, R, Capobianco, G, et al. Tumor flare reactions and response to lenalidomide in patients with refractory classic Hodgkin lymphoma. Am J Hematol, 2010;85;87-90.
- Eve, HE, Rule, SA. Lenalidomide-induced tumour flare reaction in mantle cell lymphoma. Br J Haematol, 2010;151;410-412.
Previous Article
